Identification of novel autoantibodies for detection of malignant mesothelioma.

PubWeight™: 0.77‹?›

🔗 View Article (PMC 3747111)

Published in PLoS One on August 19, 2013

Authors

Xufei Zhang1, Weike Shen, Xiaomin Dong, Jiangping Fan, Lixia Liu, Xu Gao, Kemp H Kernstine, Li Zhong

Author Affiliations

1: Department of Cell Biology, Hebei University College of Life Sciences, Baoding, Hebei, PR China.

Articles cited by this

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol (2007) 14.29

Autoantibody signatures in prostate cancer. N Engl J Med (2005) 7.56

Malignant mesothelioma. Lancet (2005) 3.93

A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. J Clin Endocrinol Metab (2003) 2.68

Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis. J Clin Invest (2001) 1.81

Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol (2006) 1.75

The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg (2002) 1.74

Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax (2007) 1.73

Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun (2001) 1.69

Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res (2007) 1.68

Asbestos-induced lung diseases: an update. Transl Res (2009) 1.66

Recent advances in the diagnosis and management of malignant pleural effusions. Mayo Clin Proc (2008) 1.66

Serologic responses in patients with malignant mesothelioma: evidence for both public and private specificities. Am J Respir Cell Mol Biol (2000) 1.62

Malignant pleural mesothelioma: a comprehensive review. Cancer Control (2006) 1.47

NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors. Cancer Res (2004) 1.44

Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res (2001) 1.39

Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol Biosyst (2013) 1.37

Establishment of a murine model of malignant mesothelioma. Int J Cancer (1992) 1.35

Autoantibody approach for serum-based detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.35

Tclass: tumor classification system based on gene expression profile. Bioinformatics (2002) 1.30

MESOMARK: a potential test for malignant pleural mesothelioma. Clin Chem (2007) 1.27

An approach to studying lung cancer-related proteins in human blood. Mol Cell Proteomics (2005) 1.25

Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One (2012) 1.24

Pleural fluid pH as a predictor of survival for patients with malignant pleural effusions. Chest (2000) 1.22

Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2: Prognosis and staging. Cancer (1993) 1.17

Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med (2005) 1.13

Pleural malignant mesothelioma and non-occupational exposure to asbestos in Casale Monferrato, Italy. Occup Environ Med (1995) 1.11

Construction of two mathematical models for prediction of bacterial sRNA targets. Biochem Biophys Res Commun (2008) 1.05

Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival. BMC Med Genomics (2011) 1.04

Treatment of malignant mesothelioma. World J Surg (2001) 1.04

Serum and pleural fluid biomarkers for mesothelioma. Curr Opin Pulm Med (2009) 1.00

Normalization benefits microarray-based classification. EURASIP J Bioinform Syst Biol (2006) 0.99

Megakaryocyte potentiating factor as a tumor marker of malignant pleural mesothelioma: evaluation in comparison with mesothelin. Lung Cancer (2008) 0.93

CYFRA 21-1 serum analysis in patients with esophageal cancer. Clin Cancer Res (2000) 0.92

How many genes are needed for early detection of breast cancer, based on gene expression patterns in peripheral blood cells? Breast Cancer Res (2005) 0.92

Serologically defined colon cancer antigen 3 is necessary for the presentation of TNF receptor 1 on cell surface. DNA Cell Biol (2005) 0.92

Markers for the non-invasive diagnosis of mesothelioma: a systematic review. Br J Cancer (2011) 0.92

National Mesothelioma Virtual Bank: a standard based biospecimen and clinical data resource to enhance translational research. BMC Cancer (2008) 0.92

Comparison of different approaches for comparative genetic analysis using microarray hybridization. Appl Microbiol Biotechnol (2006) 0.91

[Mesothelioma registry of the Liguria region. Incidence and occupational etiology in a high risk area]. Epidemiol Prev (2001) 0.90

Identification by means of cDNA microarray analyses of gene expression modifications in squamous non-small cell lung cancers as compared to normal bronchial epithelial tissue. Int J Oncol (2005) 0.90

Preprocessing differential methylation hybridization microarray data. BioData Min (2011) 0.89

Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics. Radiother Oncol (2009) 0.88

Serum anti-p53 autoantibodies in pleural malignant mesothelioma, lung cancer and non-neoplastic lung diseases. Lung Cancer (2003) 0.87

Profiling tumor-associated markers for early detection of malignant mesothelioma: an epidemiologic study. Cancer Epidemiol Biomarkers Prev (2008) 0.87

The serologically defined colon cancer antigen-3 interacts with the protein tyrosine phosphatase PTPN13 and is involved in the regulation of cytokinesis. Oncogene (2012) 0.87

Epidemiology of malignant mesothelioma in Australia. Lung Cancer (2004) 0.86

Mesothelioma: a review. Ochsner J (2012) 0.86

Suppression of IGHG1 gene expression by siRNA leads to growth inhibition and apoptosis induction in human prostate cancer cell. Mol Biol Rep (2012) 0.85

The presence of IGHG1 in human pancreatic carcinomas is associated with immune evasion mechanisms. Pancreas (2011) 0.85

Characterization of germline copy number variation in high-risk African American families with prostate cancer. Prostate (2012) 0.84

Serological antibodies against LY6K as a diagnostic biomarker in esophageal squamous cell carcinoma. Biomarkers (2012) 0.84

Anti-p53 in breast cancer: concordance of different assay procedures and association with p53 antigen expression. Oncology (2002) 0.84

Importance of CEA and CA 15-3 during disease progression in metastatic breast cancer patients. Anticancer Res (2007) 0.83

Gene expression profiling in women with breast cancer in a Saudi population. Saudi Med J (2008) 0.83

Loss of heterozygosity and internal tandem duplication mutations of the CBP gene are frequent events in human esophageal squamous cell carcinoma. Clin Cancer Res (2004) 0.83

Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model. Cancer Immunol Immunother (1994) 0.83

Tumor associated antigen recognition by autologous serum in patients with breast cancer. Int J Mol Med (2005) 0.82

Asbestos exposure, lung cancer and asbestosis. Monaldi Arch Chest Dis (2000) 0.80

Functional analysis of the CXXC motif using phage antibodies that cross-react with protein disulphide-isomerase family proteins. Biochem J (2004) 0.79

p53 autoantibodies in patients with malignant mesothelioma: stability through disease progression. Br J Cancer (2001) 0.79

[Diagnostic biomarkers of malignant pleural mesothelioma]. Med Clin (Barc) (2009) 0.76

Auto-antibodies to β-F1-ATPase and vimentin in malignant mesothelioma. PLoS One (2011) 0.76

Articles by these authors

In situ observation of the electrochemical lithiation of a single SnO₂ nanowire electrode. Science (2010) 3.58

High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors. Mol Ther (2008) 2.93

Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci U S A (2007) 2.91

Updating the East Asian mtDNA phylogeny: a prerequisite for the identification of pathogenic mutations. Hum Mol Genet (2006) 2.89

Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev (2012) 2.70

RNA-seq analysis of prostate cancer in the Chinese population identifies recurrent gene fusions, cancer-associated long noncoding RNAs and aberrant alternative splicings. Cell Res (2012) 2.41

Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J Thorac Oncol (2011) 2.41

Murine embryonic stem cell differentiation is promoted by SOCS-3 and inhibited by the zinc finger transcription factor Klf4. Blood (2004) 2.35

Devices for lung isolation used by anesthesiologists with limited thoracic experience: comparison of double-lumen endotracheal tube, Univent torque control blocker, and Arndt wire-guided endobronchial blocker. Anesthesiology (2006) 2.31

High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci U S A (2007) 2.10

XRCC3 T241M polymorphism and bladder cancer risk: a meta-analysis. Urology (2010) 2.08

MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation. Circulation (2010) 2.07

First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep (2014) 2.00

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest (2005) 1.89

Size-dependent fracture of silicon nanoparticles during lithiation. ACS Nano (2012) 1.87

The genomics of selection in dogs and the parallel evolution between dogs and humans. Nat Commun (2013) 1.86

The microRNA-328 regulates hypoxic pulmonary hypertension by targeting at insulin growth factor 1 receptor and L-type calcium channel-α1C. Hypertension (2012) 1.84

Management of forgotten ureteral stents with holmium laser. Lasers Med Sci (2008) 1.80

Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4. Nat Genet (2012) 1.78

High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines. Mol Ther (2010) 1.78

Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina. Mol Ther (2010) 1.77

Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer (2013) 1.73

Long-term, efficient inhibition of microRNA function in mice using rAAV vectors. Nat Methods (2012) 1.67

Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol (2013) 1.64

Overexpression of aldehyde dehydrogenase-2 attenuates chronic alcohol exposure-induced apoptosis, change in Akt and Pim signalling in liver. Clin Exp Pharmacol Physiol (2009) 1.53

MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J Clin Invest (2013) 1.49

Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity. Hum Gene Ther (2007) 1.44

DNA methylation biomarkers for lung cancer. Tumour Biol (2011) 1.35

Anisotropic swelling and fracture of silicon nanowires during lithiation. Nano Lett (2011) 1.33

The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 modulates apoptosis and proliferation through reciprocal regulation of androgen receptor. Urol Oncol (2012) 1.33

Systematic confirmation study of reported prostate cancer risk-associated single nucleotide polymorphisms in Chinese men. Cancer Sci (2011) 1.32

Adeno-associated virus type 2-mediated gene transfer: role of cellular T-cell protein tyrosine phosphatase in transgene expression in established cell lines in vitro and transgenic mice in vivo. J Virol (2003) 1.30

Transurethral seminal vesiculoscopy using a 6F vesiculoscope for ejaculatory duct obstruction: initial experience. J Androl (2011) 1.29

Large-scale mtDNA screening reveals a surprising matrilineal complexity in east Asia and its implications to the peopling of the region. Mol Biol Evol (2010) 1.29

Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3. Hum Gene Ther (2010) 1.26

Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle. Hum Gene Ther (2010) 1.26

MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Cancer Lett (2013) 1.24

Metallothionein alleviates oxidative stress-induced endoplasmic reticulum stress and myocardial dysfunction. J Mol Cell Cardiol (2009) 1.21

Role of cellular FKBP52 protein in intracellular trafficking of recombinant adeno-associated virus 2 vectors. Virology (2006) 1.21

Ultrafast electrochemical lithiation of individual Si nanowire anodes. Nano Lett (2011) 1.19

A comparison of a left-sided Broncho-Cath with the torque control blocker univent and the wire-guided blocker. Anesth Analg (2003) 1.18

Improving Adherence to Antiretroviral Therapy With Triggered Real-time Text Message Reminders: The China Adherence Through Technology Study. J Acquir Immune Defic Syndr (2015) 1.17

High-efficiency transduction of fibroblasts and mesenchymal stem cells by tyrosine-mutant AAV2 vectors for their potential use in cellular therapy. Hum Gene Ther (2010) 1.17

Coexpression of an intronic microRNA and its host gene reveals a potential role for miR-483-5p as an IGF2 partner. Mol Cell Endocrinol (2010) 1.16

miR-1 exacerbates cardiac ischemia-reperfusion injury in mouse models. PLoS One (2012) 1.15

Replication and cumulative effects of GWAS-identified genetic variations for prostate cancer in Asians: a case-control study in the ChinaPCa consortium. Carcinogenesis (2011) 1.15

Autoantibodies as potential biomarkers for breast cancer. Breast Cancer Res (2008) 1.13

Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer. J Mol Med (Berl) (2012) 1.12

MiR-483-5p controls angiogenesis in vitro and targets serum response factor. FEBS Lett (2011) 1.12

Activation of adenosine 2A receptors preserves structure and function of podocytes. J Am Soc Nephrol (2007) 1.12

Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells. J Androl (2006) 1.11

Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1-7/Mas axis. Am J Physiol Lung Cell Mol Physiol (2011) 1.11

Helical tomotherapy for radiotherapy in esophageal cancer: a preferred plan with better conformal target coverage and more homogeneous dose distribution. Med Dosim (2007) 1.10

Predictive performance of prostate cancer risk in Chinese men using 33 reported prostate cancer risk-associated SNPs. Prostate (2011) 1.10

Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers. Mol Cancer Res (2008) 1.10

13C-tracer and gas chromatography-mass spectrometry analyses reveal metabolic flux distribution in the oleaginous microalga Chlorella protothecoides. Plant Physiol (2010) 1.10

β-Actin is predicted as one of the potential targets of miR-145: choose internal control gene in verification of microRNA target. Carcinogenesis (2012) 1.09

A large and functionally diverse family of Fad2 genes in safflower (Carthamus tinctorius L.). BMC Plant Biol (2013) 1.08

Poor correspondence between clinical and pathologic staging in stage 1 non-small cell lung cancer: results from CALGB 9761, a prospective trial. Lung Cancer (2005) 1.05

Placement of ureteral stent after uncomplicated ureteroscopy: do we really need it? Urology (2011) 1.05

Enhanced long-term transduction and multilineage engraftment of human hematopoietic stem cells transduced with tyrosine-modified recombinant adeno-associated virus serotype 2. Hum Gene Ther (2010) 1.05

Distilling artificial recombinants from large sets of complete mtDNA genomes. PLoS One (2008) 1.04

11,11'-dideoxy-verticillin: a natural compound possessing growth factor receptor tyrosine kinase-inhibitory effect with anti-tumor activity. Anticancer Drugs (2005) 1.04

Age-specific PSA reference ranges in Chinese men without prostate cancer. Asian J Androl (2008) 1.04

Production and discovery of novel recombinant adeno-associated viral vectors. Curr Protoc Microbiol (2012) 1.02

Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance. J Clin Endocrinol Metab (2011) 1.02

TIPE2, a novel regulator of immunity, protects against experimental stroke. J Biol Chem (2012) 1.02

Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo. Cytotherapy (2013) 1.01

Heme oxygenase-1 prevents cardiac dysfunction in streptozotocin-diabetic mice by reducing inflammation, oxidative stress, apoptosis and enhancing autophagy. PLoS One (2013) 1.00

Neuroform stent-assisted coiling of intracranial aneurysms: a 5 year single-center experience and follow-up. Neurol Res (2009) 0.99

Perturbation of a very late step of regulated exocytosis by a secretory carrier membrane protein (SCAMP2)-derived peptide. J Biol Chem (2002) 0.99

Fen1 mutations that specifically disrupt its interaction with PCNA cause aneuploidy-associated cancer. Cell Res (2011) 0.98

Secretory carrier membrane protein SCAMP2 and phosphatidylinositol 4,5-bisphosphate interactions in the regulation of dense core vesicle exocytosis. Biochemistry (2007) 0.98

Optimized adeno-associated virus (AAV)-protein phosphatase-5 helper viruses for efficient liver transduction by single-stranded AAV vectors: therapeutic expression of factor IX at reduced vector doses. Hum Gene Ther (2010) 0.98

Association of inflammatory factors with occurrence and recurrence of atrial fibrillation: a meta-analysis. Int J Cardiol (2013) 0.97

Phylogeographic analysis of mitochondrial DNA haplogroup F2 in China reveals T12338C in the initiation codon of the ND5 gene not to be pathogenic. J Hum Genet (2004) 0.97

MicroRNA-93 suppress colorectal cancer development via Wnt/β-catenin pathway downregulating. Tumour Biol (2014) 0.97

Down-regulation of miR-129-5p inhibits growth and induces apoptosis in laryngeal squamous cell carcinoma by targeting APC. PLoS One (2013) 0.96

Transurethral seminal vesiculoscopy in the diagnosis and treatment of persistent or recurrent hemospermia: a single-institution experience. Asian J Androl (2009) 0.96

Lack of Transmission among Close Contacts of Patient with Case of Middle East Respiratory Syndrome Imported into the United States, 2014. Emerg Infect Dis (2015) 0.96

siRNA inhibition of telomerase enhances the anti-cancer effect of doxorubicin in breast cancer cells. BMC Cancer (2009) 0.96

PTK7 regulates myosin II activity to orient planar polarity in the mammalian auditory epithelium. Curr Biol (2012) 0.96

Plateau effect of prostate cancer risk-associated SNPs in discriminating prostate biopsy outcomes. Prostate (2013) 0.96

Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2013) 0.96

Stable integration of recombinant adeno-associated virus vector genomes after transduction of murine hematopoietic stem cells. Hum Gene Ther (2008) 0.95

Is endoscopic management suitable for long ureteral fibroepithelial polyps? J Endourol (2008) 0.95

Chronic psychological stress induces the accumulation of myeloid-derived suppressor cells in mice. PLoS One (2013) 0.95

Overexpression of microRNA-1 causes atrioventricular block in rodents. Int J Biol Sci (2013) 0.94

Subpathway-GM: identification of metabolic subpathways via joint power of interesting genes and metabolites and their topologies within pathways. Nucleic Acids Res (2013) 0.94

An animal model of PDH deficiency using AAV8-siRNA vector-mediated knockdown of pyruvate dehydrogenase E1α. Mol Genet Metab (2010) 0.93

Laser optical sensor, a label-free on-plate Salmonella enterica colony detection tool. MBio (2014) 0.93

A pharmacokinetic/pharmacodynamic mathematical model accurately describes the activity of voriconazole against Candida spp. in vitro. Int J Antimicrob Agents (2008) 0.92

[Association between single-nucleotide polymorphisms in estrogen receptor beta gene and risk of prostate cancer]. Zhonghua Wai Ke Za Zhi (2005) 0.91

Population size and time since island isolation determine genetic diversity loss in insular frog populations. Mol Ecol (2014) 0.91

Pyruvate dehydrogenase complex deficiency caused by ubiquitination and proteasome-mediated degradation of the E1 subunit. J Biol Chem (2007) 0.91

Increased expression of ABCB6 enhances protoporphyrin IX accumulation and photodynamic effect in human glioma. Ann Surg Oncol (2012) 0.91

Selective in vivo targeting of human liver tumors by optimized AAV3 vectors in a murine xenograft model. Hum Gene Ther (2014) 0.91

High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo. PLoS One (2013) 0.91

Discovery of the autonomously replicating plasmid pMF1 from Myxococcus fulvus and development of a gene cloning system in Myxococcus xanthus. Appl Environ Microbiol (2008) 0.91